SCHEMBL31489334

SCHEMBL31489334

Cc1c(-c2nc(-c3cnn([C@H](c4ccc(F)cc4)C(C)(F)F)c3)ncc2F)ccn2nc(-n3c(C)ccc3C)nc12

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31489554 0.94 NTRK1 (0.32) NTRK1
SCHEMBL31489280 0.90 NTRK1 (0.33) NTRK1
SCHEMBL31489708 0.88 PIK3CD (0.32)
SCHEMBL31489623 0.86 ROCK2 (0.31)
SCHEMBL31489773 0.85 PIK3CD (0.33) NTRK1
SCHEMBL31489730 0.84 ROCK2 (0.31)
SCHEMBL31489326 0.82 PIK3CD (0.34) NTRK1
SCHEMBL31489537 0.81
SCHEMBL31489275 0.81
SCHEMBL31489291 0.80 JAK2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072395-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 WO disclosed